1. Home
  2. ALRS vs ANAB Comparison

ALRS vs ANAB Comparison

Compare ALRS & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALRS
  • ANAB
  • Stock Information
  • Founded
  • ALRS 1879
  • ANAB 2005
  • Country
  • ALRS United States
  • ANAB United States
  • Employees
  • ALRS N/A
  • ANAB N/A
  • Industry
  • ALRS Major Banks
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALRS Finance
  • ANAB Health Care
  • Exchange
  • ALRS Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • ALRS 589.1M
  • ANAB 600.4M
  • IPO Year
  • ALRS 2019
  • ANAB 2017
  • Fundamental
  • Price
  • ALRS $22.39
  • ANAB $23.28
  • Analyst Decision
  • ALRS Hold
  • ANAB Buy
  • Analyst Count
  • ALRS 4
  • ANAB 11
  • Target Price
  • ALRS $23.25
  • ANAB $54.64
  • AVG Volume (30 Days)
  • ALRS 81.2K
  • ANAB 623.5K
  • Earning Date
  • ALRS 01-22-2025
  • ANAB 11-05-2024
  • Dividend Yield
  • ALRS 3.62%
  • ANAB N/A
  • EPS Growth
  • ALRS N/A
  • ANAB N/A
  • EPS
  • ALRS 0.16
  • ANAB N/A
  • Revenue
  • ALRS $164,503,000.00
  • ANAB $57,172,000.00
  • Revenue This Year
  • ALRS N/A
  • ANAB $207.49
  • Revenue Next Year
  • ALRS $26.79
  • ANAB N/A
  • P/E Ratio
  • ALRS $137.42
  • ANAB N/A
  • Revenue Growth
  • ALRS N/A
  • ANAB 282.17
  • 52 Week Low
  • ALRS $18.05
  • ANAB $13.36
  • 52 Week High
  • ALRS $25.85
  • ANAB $41.31
  • Technical
  • Relative Strength Index (RSI)
  • ALRS 51.75
  • ANAB 46.62
  • Support Level
  • ALRS $21.36
  • ANAB $18.03
  • Resistance Level
  • ALRS $23.44
  • ANAB $22.94
  • Average True Range (ATR)
  • ALRS 0.64
  • ANAB 1.36
  • MACD
  • ALRS 0.02
  • ANAB 0.64
  • Stochastic Oscillator
  • ALRS 55.13
  • ANAB 98.00

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: